↓ Skip to main content

The role of neoantigen in immune checkpoint blockade therapy

Overview of attention for article published in Experimental Hematology & Oncology, November 2018
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#24 of 129)
  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
7 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The role of neoantigen in immune checkpoint blockade therapy
Published in
Experimental Hematology & Oncology, November 2018
DOI 10.1186/s40164-018-0120-y
Pubmed ID
Authors

Ming Yi, Shuang Qin, Weiheng Zhao, Shengnan Yu, Qian Chu, Kongming Wu

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 67 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 18%
Researcher 11 16%
Student > Master 9 13%
Other 7 10%
Student > Ph. D. Student 6 9%
Other 9 13%
Unknown 13 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 16 24%
Immunology and Microbiology 12 18%
Agricultural and Biological Sciences 6 9%
Medicine and Dentistry 5 7%
Computer Science 5 7%
Other 7 10%
Unknown 16 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2019.
All research outputs
#3,806,655
of 14,501,785 outputs
Outputs from Experimental Hematology & Oncology
#24
of 129 outputs
Outputs of similar age
#123,894
of 373,071 outputs
Outputs of similar age from Experimental Hematology & Oncology
#10
of 22 outputs
Altmetric has tracked 14,501,785 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 129 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 373,071 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.